ANTI-SARS-COV-2 ANTIBODIES IN MACEDONIAN HEALTHCARE WORKERS: AN INTERIM ANALYSIS
Keywords:
SARS-CoV-2, COVID-19, healthcare workers, IgM, IgG antibodiesAbstract
The spectrum of COVID-19 in adults ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction.
Healthcare workers (HCWs) are exposed to the virus at a greater extent than society as a whole and may be considered at an elevated risk of infection.
The aim of the study was to estimate the seroprevalence of SARS-CoV-2 antibodies among HCWs all over the territory of North Macedonia.
In this interim analysis, we included 2,334 healthcare workers (HCW), who were tested for serum IgM and IgG antibodies to SARS-CoV-2 virus during the period from 28/05/2020 to 20/08/2020.
Chemiluminescent (CLIA) analytical system was used for detection of anti SARS CoV-2 IgM and IgG antibodies.
A total of 195 HCWs, out of 2,334, tested positive for either IgM or IgG anti-SARS-CoV-2 serum antibodies (IgM/G+). Of these, 167 individuals tested positive for IgM antibodies (IgM+) and 54 tested positive for IgG antibodies (IgG+). Based on these data, the cumulative incidence of anti-SARS-CoV-2 antibodies in HCWs during the period from 28/05/2020 to 20/08/2020 was estimated at 8.355% (95% CI = 7.279-9.57%).
HCWs represent a population at high risk of contracting COVID-19. To decrease the risk of SARS-CoV-2 infection, absolute adherence to infection preventive measures is needed: proper use of face masks at all times in the workplace, avoiding of overcrowding in different working spaces, and keeping a recommended distance in meetings, clinical handouts and work meals. Early identification and isolation of infected HCWs is highly recommended.
References
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020.
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportionof coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25:2000180.
Lippi G, Plebani M. The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge. Diagnosis (Berl) 2020;7:79–81.
Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med 2020;9. pii: E623. doi: https://doi.org/10.3390/jcm9030623.
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020;7:4.
Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 2020;58:1070–6
Bendavid E, Mulaney B, Sood N, Shah S, Ling E, Bromley Dulfano R, et al. COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv 2020. 04.14.20062463.
Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, et al. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10e11, 2020. JAMA 2020;323:2425e7.
Rosenberg ES, Tesoriero JM, Rosenthal EM, Chung R, Barranco M, Styer LM, et al. Cumulative incidence and diagnosis of SARS-CoV2 infection in New York. Ann Epidemiol 2020;48:23e9.
Biggs HM, Harris JB, Breakwell L, Dahlgren FS, Abedi GR, Szablewski CM, et al. Estimated community seroprevalence of SARS-CoV-2 antibodies - two Georgia counties, April 28eMay 3, 2020. MMWR 2020;69:965e70.
Menachemi N, Yiannoutsos CT, Dixon BE, Duszynski TJ, Fadel WF, Wools-Kaloustian KK, et al. Population point prevalence of SARS-CoV-2 infection based on a statewide random sample - Indiana, April 25e29, 2020. MMWR 2020;69:960e4.
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a populationbased study. Lancet 2020;396:313e9.
Polla´n M, Pe´rez-Go´mez B, Pastor-Barriuso R, Oteo J, Herna´n MA, Pe´rez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENECOVID): a nationwide, population-based seroepidemiological study. Lancet 2020;396:535e44.
Bogogiannidou Z, Vontas A, Dadouli K, Kyritsi MA, Soteriades S, Nikoulis DJ, et al. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020. Euro Surveill 2020;25:2001369.
Xu T, Ao M, Zhou X, Zhu WF, Nie HN, Fang JH, et al. China’s practice to prevent and control COVID-19 in the context of large population movement. Infect Dis Poverty 2020;9:115.
Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect 2021 Feb;108:120-134.
Sahu AK, Amrithanand VT, Mathew R, Aggarwal P, Nayer J, Bhoi S. COVID-19 in health care workers - a systematic review and meta-analysis. Am J Emerg Med 2020;38:1727-31.
Rudberg AS, Havervall S, Månberg A, Falk AJ, Aguilera K, Ng H, Gabrielsson L, Salomonsson AC, Hanke L, Murrell B, McInerney G, Olofsson J, Andersson E, Hellström C, Bayati S, Bergström S, Pin E, Sjöberg R, Tegel H, Hedhammar M, Phillipson M, Nilsson P, Hober S, Thålin C. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 11, 5064 (2020). https://doi.org/10.1038/s41467-020-18848-0
Plebani M, Padoan A, Fedeli U, Schievano E, Vecchiato E, Lippi G, et al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med 2020;58(12):2107–11.
Hunter DJ. Covid-19 and the stiff upper lip e the pandemic response in the United Kingdom. N Engl J Med 2020;16:382.
Canova V, Lederer Schlapfer H, Piso RJ, Droll A, Fenner L, Hoffmann T, et al. Transmission risk of SARS-CoV-2 to healthcare workers - observational results of a primary care hospital contact tracing. Swiss Med Wkly 2020;150:w20257.
Banik RK, Ulrich AK. Evidence of short-range aerosol transmission of SARS-CoV-2 and call for universal airborne precautions for anesthesiologists during the COVID-19 pandemic. Anesth Analg 2020;131:e102e4.
Wilson NM, Norton A, Young FP, Collins DW. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia 2020;75:1086e95.
McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med 2020;21:382.
Godderis L, Boone A, Bakusic J. COVID-19: a new work-related disease threatening healthcare workers. Occup Med 2020;70:315e6.
Schwartz J, King CC, Yen MY. Protecting health care workers during the coronavirus disease 2019 (COVID-19) outbreak: lessons from Taiwan’s severe acute respiratory syndrome response. Clin Infect Dis 2020;71:858e60.
Verbeek JH, Ijaz S, Mischke C, Ruotsalainen JH, Ma¨kela¨ E, Neuvonen K, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev 2016;4:CD011621.
Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020;8:e13.
Wang J, Zhou M, Liu F. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect 2020;105:100e1.
Grant JJ, Wilmore S, McCann NS, Donnelly O, Lai R, Kinsella MJ, et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS trust. Infect Control Hosp Epidemiol 2020;4:1e3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054e62.
Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, . Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis 2020; 22:ciaa638.
Steensels D, Oris E, Coninx L, Nuyens D, Delforge ML, Vermeersch P. Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium. JAMA 2020;324:195e7
Belingheri M, Paladino ME, Riva MA. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers. J Hosp Infect 2020;105:353.
